Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T12:50:58.685Z.
Calculation as of: 2026-10-06T12:50:58.685Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b8816454c8f8663c3bedc847144af8f107147f6cc2e90a46c8541497c2a45775
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Market Cap
$6.50B
Operating Cash Flow Yield
3.09%
TTM Avg
6.96%
3Y Avg
12.38%
5Y Avg
19.52%
Market Cap
$5.53B
Operating Cash Flow Yield
N/A
TTM Avg
9.45%
3Y Avg
5.30%
5Y Avg
5.30%
Market Cap
$6.62B
Operating Cash Flow Yield
4.03%
TTM Avg
4.34%
3Y Avg
3.15%
5Y Avg
2.87%
Market Cap
$6.68B
Operating Cash Flow Yield
5.84%
TTM Avg
6.63%
3Y Avg
5.04%
5Y Avg
4.66%
Market Cap
$5.35B
Operating Cash Flow Yield
5.73%
TTM Avg
5.66%
3Y Avg
3.61%
5Y Avg
2.96%
Market Cap
$5.27B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CG Oncology Inc. (CGON) | $6.06B | N/A | N/A | N/A | N/A |
| Amneal Pharmaceuticals, Inc. (AMRX)vs › | $6.50B | 3.09% | 6.96% | 12.38% | 19.52% |
| CRISPR Therapeutics AG (CRSP)vs › | $5.53B | N/A | 9.45% | 5.30% | 5.30% |
| GRAIL Inc. (GRAL)vs › | $6.61B | N/A | N/A | N/A | N/A |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.62B | 4.03% | 4.34% | 3.15% | 2.87% |
| Chemed Corporation (CHE)vs › | $6.68B | 5.84% | 6.63% | 5.04% | 4.66% |
| Doximity, Inc. (DOCS)vs › | $5.35B | 5.73% | 5.66% | 3.61% | 2.96% |
| Cogent Biosciences, Inc. (COGT)vs › | $5.27B | N/A | N/A | N/A | N/A |
| Immunovant, Inc. (IMVT)vs › | $6.86B | N/A | N/A | N/A | N/A |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.20B | 5.45% | 6.10% | 4.38% | 3.97% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
